EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Weak opioids management and prescription’s reassessment by general practioners in elderlies after hospitalization?

Colin VESES, Françoise CAPRIZ, Olivier GUÉRIN

Revue de gériatrie · 2022

DOI: 10.62581/revgeri.17656 ↗
AbstractBibliografische Angaben

Abstract

Context: Weak opioids are, after paracetamol, the most prescribed analgesics in France. The aging population has frequent pain. However, few studies are representative of “fragile” painful elderly patients, a common profile in community medicine. The aim of this study was to monitor the follow up of week opioids by general practitioners in elderlies after hospitalization. Methods: We included patients above 75 years exiting geriatric hospitalization between April and August 2021 with weak opioids, and performed a follow up of the prescription by calling their general practician (GP) after one month. Results and discussion: Tramadol was the most prescribed. Amongst the 48 patients enrolled, the majority had their prescription renew (n=27); most of them unchanged (n=20). The reason number one for opioid’s interruption (n=21) was pain disappearance (n=15), followed by drugs adverse event or the fear for such side effects. 7 patients showed opioid’s intolerance symptoms. In this case, GP either chose to interrupt or lower opioid’s dose for 6 patients. They switched to another opioid in only one case and never prescribed strong opioid in that situation. Strong opioid had only been considered when weak opioid revealed insufficient to relieve increasing pain. However, it would be interesting to choose analgesics according to their mechanism of action and the particularities of each patient. Recent pharmacogenetics concepts, and the taxonomic classification of Lussier and Beaulieu must penetrate more into everyday practice in order to prescribe difficult-to-handle opioids in the most rational, effective and safe way possible. Conclusion: When facing opioid side effects among their aged patients, general practitioners prefer to interrupt the treatment or lower the drug dose instead of introducing low doses of strong opioids. Molecule switching amongst weak opioids is rarely considered in that situation even if pharmaco-genetic mechanisms could be involved in some of the drug related side effects.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →